Acumen Pharmaceuticals Q2 EPS $(0.68) Misses $(0.52) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings MissesNews
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.52) by 31.53 percent. This is a 100 percent decrease over losses of $(0.34) per share
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.52) by 31.53 percent. This is a 100 percent decrease over losses of $(0.34) per share from the same period last year.